HealthQuest Capital’s Post

HealthQuest Capital reposted this

View organization page for Alcresta Therapeutics, graphic

2,334 followers

Alcresta Therapeutics is excited to share that the Next-Generation of RELiZORB is now commercially available. For more information, please see the press release here: https://lnkd.in/exqRjaNH RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE is indicated for use in pediatric patients (ages 2 years and above) and adult patients to hydrolyze fats in enteral formula. RELiZORB is for use with enteral feeding only; do not connect to intravenous or other medical tubing. Medications should not be administered through RELiZORB. For more information and full safety information, visit www.relizorb.com.

Alcresta Therapeutics | Enzyme products designed for enteral nutrition

Alcresta Therapeutics | Enzyme products designed for enteral nutrition

alcresta.com

To view or add a comment, sign in

Explore topics